Correction: Pneumococcal vaccine for prevention of acute otitis media in children: a meta-analysis Authors: Liyuan Han, Chunyan Gao, Jie Liu, Yanhua Li, Minglei Liu, Huimiao Liu, Jinghua Wu Published: 2026 Correction: BMC Infectious Diseases (2026) 26:412 10.1186/s12879-026-12651-w The entries in Table 1 were incorrect in the published article. The incorrect and corrected tables are given below. Incorrect table Correct table, Table 1The basic characteristics of literaturestudycountrytypepatientstreatmentnagegender (F/M)outcomeJunko Hasegawa2015JapanRCTacute otitis mediaPCV730627.6 ± 13.5154/152incidence of AOMcontrol30849.0 ± 11.0165/143Ovnat Tamir.S2015IsraelRCTacute otitis mediaintervention6518 ± 1226/39Fever ≥ 38.5 °C、Concurrent positive blood culture、Bilateral AOM episodes、Acute mastoiditiscontrol4120 ± 1219/22Sinikka Karppinen2019FinlandRCTrespiratory tract infections (RTIs)PCV10236113/123RTIs with AOMcontrol13259/73Hildigunnur Sveinsdóttir2019IcelandRCTacute otitis mediaPCV102094Samples positive for H. influenzaecontrol2859Sharon Ovnat Tamir.MD2015IsraelRCTacute otitis mediaPCV7 + PCV131651670/95Bilateral AOM episodes、Acute mastoiditis、Concomitant positive blood culture、Children with rAOMcontrol1302447/83Sangho Sohn, M.D.Ph.D2020KoreaRCTacute otitis mediaPCV13 + PCV10967,17032.5 ± 8.6471,761/495,409incidence of AOMcontrol23,05433.9 ± 8.811,688/11,366Tal Marom.MD2021IsraelRCTacute otitis mediaPCV-7/PCV-13146,03668,585/77,447Asthma、Allergy、Children with rAOMcontrol124,10160,587/63,514Simon Imer Jespersen2021DenmarkRCTacute otitis mediaPCV13742368/374Total number of AOM episodescontrol335166/169Aurélie Allemann2017SwitzerlandRCTacute otitis mediaPCV7 + PCV13961417/536Nasopharyngeal swab was positive for pneumococcal culturecontrol1588732/851Robert Cohen2012FranceRCTacute otitis mediaPCV72,59813.8 ± 5.11222/1376Fever (≥ 38.5 °C)control1.80714.6 ± 7.6837/970Maria C. Magnus.MPH2012NorwayRCTacute otitis mediaPCV722,777incidence of AOMcontrol33,902 The basic characteristics of literature In this article Fig. 7 appeared as Forest plot of the recurrent AOM but should have appeared as Forest plot of the recurrent AOM In the sentence beginning ‘The analysis included eleven studies encompassing’ in this article, 1,331,407 should have read 1,329,602. In the sentence beginning ‘a significant increase in the incidence of fever (≥ 38.5°C) [RR = 1.370, 95% CI (1.272, 1.467), P < 0.001]’ in this article, as well as a significantly higher incidence of recurrent acute otitis media [RR = 1.053, 95% CI (1.040, 1.065), P < 0.001] should have read as well as a significantly lower incidence of recurrent acute otitis media [RR = 0.984, 95%Cl (0.981, 0.988), P < 0.001]. In the sentence beginning ‘Figure 1 presents the flow of study selection, and Table 1 provides a detailed overview of the included studies’ in this article, Eleven studies with 1,331,407 patients—1,143,150 in the experimental group and 188,257 in the control group should have read Eleven studies with 1,329,602 patients—1,143,150 in the experimental group and 186,452 in the control group. In the sentence beginning ‘Two studies [21, 25] reported the incidence of recurrent acute otitis media (AOM) as a complication’ in this article, (P = 0.426, I² = 0.0%), a fixed effects model was applied. The analysis demonstrated that, compared with the control group, the vaccine group had a significantly higher incidence of recurrent AOM (RR = 1.05, 95% CI: 1.04–1.07, p < 0.001) (Fig. 7). Begg’s test indicated no evidence of significant publica tion bias (p = 0.317) (Figure S9) should have read (P = 0.607, I² = 0.0%), a fixed-effects model was applied. The analysis demonstrated that, compared with the control group, the vaccine group had a significantly lower incidence of recurrent AOM (RR = 0.98, 95% CI: 0.98–0.99, p < 0.001) (Fig. 7). Begg’s test indicated no evidence of significant publication bias ( p = 0.317) (Figure S9). In the sentence beginning ‘For effectiveness, we did not observe a clear reduction in overall AOM incidence’ in this article, and the estimate for recurrent AOM suggested a possible increase in risk should have read and the estimate for recurrent AOM suggested a possible decrease in risk. In the sentence beginning ‘Prior reviews highlight context-dependent’ in this article, For recurrent AOM, the pooled estimate suggested a possible increase in risk, but this finding was imprecise, varied across studies, and sus ceptible to residual confounding (e.g., serotype coverage, healthcare-seeking behavior, baseline risk). This may be due to the numerous bacterial subtypes, with newer vac cines targeting these variants, potentially leading to fur ther pneumococcal mutations [48, 49]. should have read The research suggested a markedly decrease in the occurrence of recurrent AOM in infants diagnosed with AOM during the first 2 months of life and timely immunized with PCVs following this initial AOM episode [49]. The results of this study suggest that vaccination could potentially reduce the incidence of recurrent otitis media. However, due to the limited number of included studies and the small sample sizes in some of them, there is insufficient evidence to support this conclusion. Therefore, this finding should be interpreted with caution when considering its application in clinical practice and policy recommendations, and further high-quality, multicentre studies are needed to confirm these findings. The original article has been corrected. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.